An Efficacy and Safety Trial of Serostim® in the Maintenance of the Treatment Effect Obtained During the Study of Serostim® in Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome

Clinical trial NCT00294918 · COMPLETED

Trial details

NCT number: NCT00294918
Sponsor: EMD Serono
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)Human Immunodeficiency Virus Infections

Start date: 2001-09-01
Primary completion: 2003-02-01
Enrollment: 142

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.